Infliximab trough levels and anti-drug antibodies after induction predict long-term clinical remission in infliximab-treated patients with inflammatory bowel disease

被引：0
|
作者：
Bodini, G. [1 ]
Del Nero, L. [1 ]
Giannini, E. G. [1 ]
Tolone, S. [2 ]
De Bortoli, N. [3 ]
Anjali, J. [4 ]
Baldissarro, I. [1 ]
Savarino, V. [1 ]
Savarino, E. [5 ]
机构：
[1] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
[2] Univ Naples 2, Dept Surg, Naples, Italy
[3] Univ Pisa, Dept Internal Med, Gastroenterol Unit, Pisa, Italy
[4] Prometheus Labs, Dept Res & Dev, San Diego, CA USA
[5] Univ Padua, Dept Surg Oncol & Gastroenterol, Gastroenterol Unit, Padua, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P607
引用
收藏
页码：S408 / S409
页数：2
相关论文
共 50 条
  • [21] USEFULNESS OF MONITORING THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASES THROUGH THE DETERMINATION OF INFLIXIMAB OR ADALIMUMAB TROUGH LEVELS AND BY THE EVALUATION OF ANTI-DRUG ANTIBODIES
    Miranda, A.
    Sgambato, D.
    Ferrante, E.
    Picascia, D.
    Avallone, L.
    D'Amico, M.
    Sullo, M. G.
    Capuano, A.
    Romano, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E133 - E133
  • [22] Anti-Drug Antibodies in Patients with Inflammatory Bowel Diseases Treated with Biosimilar Infliximab: A Prospective Cohort Study
    Pekala, Anna
    Filip, Rafal
    Aebisher, David
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [23] INDUCTION ANTI-TNF DRUG LEVELS AND ANTIBODIES AT WEEK 6 IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS TREATED WITH INFLIXIMAB
    Garcia, Karoline S.
    Queiroz, Natalia S.
    Parra, Rogerio S.
    Feres, Omar
    Chebli, Julio
    Chebli, Liliana A.
    Flores, Cristina
    Vieira, Andrea
    Azevedo, Matheus
    Carlos, Alexandre S.
    Oba, Jane
    Alves, Olivia D.
    Ceara, Christianne D.
    Sipahi, Aytan M.
    Damiao, Aderson O.
    GASTROENTEROLOGY, 2022, 162 (07) : S1097 - S1097
  • [24] Anti-drug Antibodies Inhibit Neutralization of TNF-alpha in Infliximab Treated Patients with Inflammatory Bowel Disease (IBD)
    Eser, A.
    Vogelsang, H.
    Reinisch, S.
    Novacek, G.
    Dejaco, C.
    Kazemi-Shirazi, L.
    Primas, C.
    Lichtenberger, C.
    Brehovsky, S.
    Singh, S.
    Jain, A.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S304 - S305
  • [25] ANTI-DRUG ANTIBODIES (ADA): ASSAY PERFORMANCE IN PATIENTS TREATED FOR INFLAMMATORY BOWEL AND RHEUMATIC DISEASE WITH BIODRUGS, ADALIMUMAB AND INFLIXIMAB
    O'Donnell, J.
    Liu, J.
    Keating, P.
    Hock, B.
    Spellerberg, M.
    Barclay, M.
    Stamp, L.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 15 - 15
  • [26] Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
    Lee, Ji Min
    Kim, Yoon Jae
    Lee, Kang-Moon
    Yoon, Hyuk
    Lee, Bo-In
    Kim, Dae Bum
    Kang, Donghoon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10-11) : 1280 - 1285
  • [27] Comparison of 4 assay kits for measuring infliximab trough levels and antibodies to infliximab in patients with inflammatory bowel disease
    Perez, I.
    Fernandez, L.
    Sanchez-Ramon, S.
    Alba, C.
    Olivares, D.
    Mendoza, J. L.
    Rey, E.
    Taxonera, C.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S380 - S380
  • [28] Comparison of Four Assay Kits for Measuring Infliximab Trough Levels and Antibodies to Infliximab in Patients With Inflammatory Bowel Disease
    Enciso, Irene Perez
    Paredes, Lidia Fernandez
    Sanchez-Ramon, Silvia
    Mendoza, Juan L.
    Alba, Cristina
    Olivares, David
    Rey, Enrique
    Taxonera, Carlos
    GASTROENTEROLOGY, 2016, 150 (04) : S415 - S415
  • [29] THE CLINICAL AND FINANCIAL IMPACT OF MEASURING INFLIXIMAB LEVELS AND ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS
    O'Reilly, S.
    Keegan, D.
    Byrne, K.
    Sheridan, J.
    Mulcahy, H. E.
    Doherty, G. A.
    Cullen, G.
    GUT, 2017, 66 : A2 - A3
  • [30] Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
    Choi, So Yoon
    Kang, Ben
    Lee, Jee Hyun
    Choe, Yon Ho
    GUT AND LIVER, 2017, 11 (01) : 55 - 61
12345